Endometrial cancer: topicality of the issue and opportunities of rehabilitation

DOI: https://doi.org/10.29296/25877305-2020-02-02
Download full text PDF
Issue: 
2
Year: 
2020

L. Sandzhieva(1); L. Idrisova(1), Candidate of Medical Sciences; Professor A. Solopova(1, 2), MD; Professor Yu. Tabakman(2), MD; I. Ermakova(1) (1)I.M. Sechenov First Moscow State Medical University (Sechenov University) (2)Oncology Clinical Hospital One, Moscow Healthcare Department

Endometrial cancer is one of the most common gynecological cancers. The relevance of the topic is due to a rise in the number of reproductive-aged patients, which presents an acute sociomedical problem. The paper analyzes the possibilities of medical rehabilitation (diet therapy, physiotherapy, immunotherapy, etc.). It considers antitumor therapy complications that negatively affect female the life and health of women, such as sexual dysfunction, paraneoplastic fatigue syndrome, lower extremity lymphedema, radiation reactions, and postcastration syndrome, as well as methods for their correction. Methods for patient rehabilitation and early diagnosis of a relapse before its clinical manifestation are analyzed. The ultimate goal of rehabilitation is to improve quality of life in patients.

Keywords: 
онкогинекология
рак эндометрия
пререабилитация
реабилитация
качество жизни
рецидивы
физиотерапия
иммунотерапия



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Ferlay J., Ervik M., Lam F. et al. GLOBOCAN 2018, GlobalCancerObservatory: CancerToday. LyonFrance: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today [Accessed: 29.07.2019].
  2. Morice P., Leary A., Creutzberg C. et al. Endometrial cancer // Lancet. – 2016; 387 (10023): 1094–108. DOI: 10.1016/S0140-6736(15)00130-0.
  3. Murali R., Soslow R., Weigelt B. Classification of endometrial carcinoma: more than two types // Lancet Oncol. – 2014; 15 (7): 268–78. DOI: 10.1016/S1470-2045(13)70591-6.
  4. Solopova A.G., Idrisova L.E., Makatsarija A.D. i dr. Mul'tidistsiplinarnyj podhod k meditsinskoj reabilitatsii onkoginekologicheskih bol'nyh // Akusherstvo, ginekologija i reproduktsija. – 2017; 11 (4): 57–67 [Solopova A.G., Idrisova L.E., Makatsariya A.D. et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients // Obstetrics, Gynecology and Reproduction. – 2017; 11 (4): 57–67 (in Russ.)]. DOI: 10.17749/2313-7347.2017.11.4.057-067.
  5. Graziottin A., Lukasiewicz M., Serafini A. Sexual Rehabilitation After Gynaecological Cancers // Cancer Int. Sex. – 2017; 205–222. DOI: 10.1007/978-3-319-43193-2_27.
  6. Huiqiao G., MeizhuX., Huimin B. et al. Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery // Int. J. Cancer. – 2017; 27 (3): 608–12. DOI: 10.1097/igc.0000000000000905.
  7. Del Pup. L., Villa P., Amar I. et al. (2019). Approach to sexual dysfunction in women with cancer // Int. J. Gynecol. Cancer. – 2019; 29 (3): 630–4. DOI: 10.1136/ijgc-2018-000096.
  8. Pagano I., Gieri S., Nocera F. et al. Evaluation of the CO2 Laser Therapy on Vulvo-Vaginal Atrophy (VVA) in Oncological Patients: Preliminary Results // J. Cancer Ther. – 2017; 8 (5): 452–63. DOI: 10.4236/jct.2017.85039.
  9. Stahl J., Qian J., Tien C. et al. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy // Supp. Care Cancer. – 2018; 27: 1425. DOI: 10.1007/s00520-018-4441-5.
  10. Delia P., Sansotta G., Pontoriero A. et al. Clinical Evaluation of Low-Molecular- Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial // Oncol. Res. Treat. – 2019; 42 (4): 217–23. DOI: 10.1159/000496036.
  11. Pilipenko N.I., Prohach N.E. Kachestvo zhizni i sindrom paraneoplasticheskoj ustalosti u onkologicheskih bol'nyh // Evrazijskij onkol. zhurn. – 2014; 1 (1): 68–76 [Pilipenko N.I., Prohach N.E. Quality of life and paraneoplastic fatigue syndrome in oncology patients // Eurasian journal of Oncology. – 2014; 1 (1): 68–76 (in Russ.)].
  12. Lokich E. Gynecologic Cancer Survivorship // Obstet. Gynecol. Clin. North Am. – 2019; 46 (1): 165–78. DOI: 10.1016/j.ogc.2018.10.002.
  13. Rossi E., Noberasco C., Picchi M. et al. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy // J. Altern. Complement Med. – 2018; 24 (9–10): 933–41. DOI: 10.1089/acm.2018.0143.
  14. Cochen C., Fontaine K., Arend R. et al. Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial // Nutrients. – 2018; 10: 1187. DOI: 10.3390/nu10091187.
  15. Do J., Choi K., Ahn J. et al. Effects of a complex rehabilitation program on edema status, physical function, and quality of life in lower-limb lymphedema after gynecological cancer surgery // Gynecol. Oncol. – 2017; 147 (2): 450–5. DOI: 10.1016/j.ygyno.2017.09.003.
  16. Beesley V., Rowlands I., Hayes S. et al. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer // Gynecol. Oncol. – 2015; 136 (1): 87–93. DOI: 10.1016/j.ygyno.2014.11.006.
  17. Thomaz J., Dias T., de Rezende L. Effect of taping as treatment to reduce breast cancer lymphedema: literature review // J. Vasc. Bras. – 2018; 17 (2): 136–40. DOI: 10.1590/1677-5449.007217.
  18. Janicki J., Chancellor M., Kaufman J. et al. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction // Toxins. – 2016; 8 (3): 81. DOI: 10.3390/toxins8030081.
  19. Wei D., Heus P., van de Wetering F. et al. Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer // Cochrane Database Syst. Rev. – 2018; 8: CD008831. DOI: 10.1002/14651858.CD008831.pub3.
  20. Cui M., Xiao H., Li Y. et al. Faecal microbiota transplantation protects against radiation-induced toxicity // EMBO Mol. Med. – 2017; 9 (4): 448–61. DOI: 10.15252/emmm.201606932.
  21. Edey K., Rundle S., Hickey M. Hormone replacement therapy for women previously treated for endometrial cancer (Review) // Cochrane Database Syst. Rev. – 2018; CD008830. DOI: 10.1002/14651858.CD008830.pub3.
  22. Angioli R., Luvero D., Armento G. et al. Hormone replacement therapy in cancer survivors: Utopia? // Crit. Rev. Oncol. Hematol. – 2018; 124: 51–60. DOI: 10.1016/j.critrevonc.2018.02.005.
  23. Hickey M., Szabo R., Hunter M. Non-hormonal treatments for menopausal symptoms // BMJ. – 2017; 359: j5101. DOI: 10.1136/bmj.j5101.
  24. Bulah O.A., Filatova E.V. Kompleksnaja reabilitatsija patsientok s postkastratsionnym sindromom // Fizioterapija, bal'neologija i reabilitatsija. – 2017; 16 (5): 249–53 [Bulakh O.A., Filatova E.V. Comprehensive rehabilitation of patients with post-castration syndrome // Fizioterapiya, bal’neologiya I reabilitatsiya. – 2017; 16 (5): 249–53 (in Russ.)]. DOI: 10.18821/1681-3456-2017-16-5-249-253.
  25. Kit O.I., Frantsijants E.M., Moiseenko T.I. i dr. Rol' plazmafereza i ksenonterapii v korrektsii ostryh posledstvij hirurgicheskoj menopauzy u bol'nyh rakom shejki matki // Nauchnyj zhurnal KubGAU. – 2016; 117 (03) [Kit O.I., Franzyants E.M., Moiseenko T.I. et al. the Role of plasmapheresis and xenon therapy in the correction of acute consequences of surgical menopause in patients with cervical cancer // Nauchnyi zhurnal KubGAU. – 2016; 117 (03) (in Russ.)].
  26. Sun X-L., Wang H-B., Wang Z-Q. et al. Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial // BMC Cancer. – 2017; 17: 416. DOI: 10.1186/s12885-017-3387-1.
  27. Ulaschik V.S. Lokal'naja gipertermija v onkologii: ispol'zovanie magnitnogo polja, lazernogo izluchenija, ul'trazvuka // Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul'tury. – 2014; 91 (2): 48–57 [Ulashchik V.S. Local hyperthermia in oncology: use of magnetic field, laser radiation, ultrasound // Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul’tury. – 2014; 91 (2): 48–57 (in Russ.)].
  28. Stepanova A.M., Merzljakova A.M., Tkachenko G.A. i dr. Fizioterapija, mehanoterapija i psihoterapija v onkologii // Vestn. vosst. med. – 2016; 5: 42–6 [Stepanova A.M., Merzlyakova A.M., Tkachenko G.A. et al. Physiotherapy, physical therapy and psychotherapy in oncology // Vestn. vosst. med. – 2016; 5: 42–6 (in Russ.)].
  29. Litvinova T.M., Kosenko I.A., Zalutskij I.V. i dr. Protivoopuholevoe i protivometastaticheskoe dejstvie vnutrivennogo lazernogo obluchenija krovi: eksperimental'noe dokazatel'stvo i ispol'zovanie pri rake tela matki // Lazernaja med. – 2012; 16 (3): 13–8 [Litvinova T.M., Kosenko I.A., Zalutskii I.V. et al. Antitumor and anti-metastatic activity of intravenous laser blood irradiation: experimental proof and use in uterine body cancer // Lazernaya med. – 2012; 16 (3): 13–8 (in Russ.)].
  30. Grushina T.I., Mironova E.E. Sanatorno-kurortnoe lechenie v komplekse reabilitatsionnyh meroprijatij u bol'nyh rakom molochnoj zhelezy // Fizioterapija, bal'neologija i reabilitatsija. – 2003; 4: 34–8 [Grushina T.I., Mironova E.E. Sanatorium and resort treatment in the complex of rehabilitation event in patients with breast cancer // Fizioterapiya, bal’neologiya i reabilitatsiya. – 2003; 4: 34–8 (in Russ.)].
  31. Kruglova L.S., Shatohina E.A., Kotenko K.V. i dr. Ispol'zovanie fizioterapevticheskih metodov v reabilitatsii bol'nyh s onkologicheskoj patologiej // Fizioterapija, bal'neologija i reabilitatsija. – 2016; 15 (2): 97–101 [Kruglova L.S., Shatokhina E.A., Kotenko K.V. et al. The use of the physical therapy methods for the rehabilitation of the patients presenting with cancer. // Fizioterapiya, bal’neologiya i reabilitatsiya. – 2016; 15 (2): 97–101 (in Russ.)]. DOI: 10.18821/1681-3456-2016-15-2-97-101.
  32. Sorbe B., Juresta C., Ahlin C. Natural history of recurrences in endometrial carcinoma // Oncol. Lett. – 2014; 8 (4): 1800–6. DOI: 10.3892/ol.2014.2362.
  33. Brennan D., Hackethal A., Mann K. et al. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance // BMC Cancer. – 2015; 15: 33. DOI: 10.1186/s2885-015-1028-0.
  34. Enqerud H., Hope K., Berq H. et al. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer // PLoS One. – 2019; 14 (1): e0210585. DOI: 10.1371/journal.pone.0210585.
  35. Troisi J., Sarno L., Landolfi A. et al. Metabolomic signature of endometrial cancer // J. Proteome Res. – 2018; 17 (2): 804–12. DOI: 10.1021/acs.jproteome.7b00503.
  36. Knific T., Vouk K., Smrkolj Š. et al. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer // J. Steroid Biochem. Mol. Biol. – 2018; 178: 312–21. DOI: 10.1016/j.jsbmb.2018.01.012. Longoria T., Escander R. Immunotherapy in endometrial cancer – an evolving therapeutic paradigm // Gynecologic Oncology Research and Practice. – 2015; 2: 11. DOI: 10.1186/s40661-015-0020-3.
  37. Jackson D., Byrd K., Vreeland T. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients // Oncotarget. – 2017; 8 (9): 15912–23. DOI: 10.18632/oncotarget.13305.
  38. Coosemans A., Vanderstraeten A., Tuyaerts S. Wilms’ Tumor Gene 1 (WT1) – loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors: A Phase I/II Clinical Trial // Anticancer Res. – 2013; 33: 5495–500.
  39. Gopalakrishnan V., Helmink B., Spencer C. et al. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy // Cancer Cell. – 2018; 33 (4): 570–80. DOI: 10.1016/j.ccell.2018.03.015.
  40. Zitvogel L., Ma Y., Raoult D. et al. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies // Science. – 2018; 359 (6382): 1366–70. DOI: 10.1126/science.aar6918.